AKTS Insider Transactions
31 retained open-market purchase and sale rows from SEC Forms 3, 4 and 5, newest first. This page shows rows 1–31; provenance stays internal.
AKTS insiders transaction timeline
PurchaseSale
| Insider profile | Role | Date | Transaction | Shares | Price |
|---|---|---|---|---|---|
| Herrmann Ken | Director | 2026-07-20 | Sale | 1,350 | $24.5622 |
| Herrmann Ken | Director | 2026-07-20 | Sale | 3,506 | $24.5622 |
| Herrmann Ken | Director | 2026-07-17 | Sale | 3,065 | $25.2067 |
| Ron-Bigger Shulamit | Chief Operating Officer | 2026-07-08 | Sale | 4,200 | $28.7476 |
| Ron-Bigger Shulamit | Chief Operating Officer | 2026-07-08 | Sale | 30,000 | $27.9379 |
| Ron-Bigger Shulamit | Chief Operating Officer | 2026-07-08 | Sale | 15,800 | $27.1317 |
| Czibere Akos | Chief Medical Officer | 2026-07-08 | Sale | 4,371 | $28.7078 |
| Czibere Akos | Chief Medical Officer | 2026-07-08 | Sale | 30,829 | $27.9521 |
| Czibere Akos | Chief Medical Officer | 2026-07-08 | Sale | 14,800 | $27.1273 |
| Foley Todd | Director,TenPercentOwner | 2026-01-12 | Purchase | 232,870.0 | $18.0 |
| EVNIN LUKE | TenPercentOwner | 2026-01-12 | Purchase | 1,112,777.0 | $18.0 |
| MPM ONCOLOGY INNOVATIONS FUND LP | TenPercentOwner | 2026-01-12 | Purchase | 1,112,777.0 | $18.0 |
| MPM BIOVENTURES 2018 (B), L.P. | TenPercentOwner | 2026-01-12 | Purchase | 1,112,777.0 | $18.0 |
| MPM BIOVENTURES 2018, L.P. | TenPercentOwner | 2026-01-12 | Purchase | 1,112,777.0 | $18.0 |
| MPM ASSET MANAGEMENT INVESTORS BV2018 LLC | TenPercentOwner | 2026-01-12 | Purchase | 1,112,777.0 | $18.0 |
| MPM BioVentures 2018 GP LLC | TenPercentOwner | 2026-01-12 | Purchase | 1,112,777.0 | $18.0 |
| MPM BioVentures 2018 LLC | TenPercentOwner | 2026-01-12 | Purchase | 1,112,777.0 | $18.0 |
| MPM Oncology Innovations Fund GP LLC | TenPercentOwner | 2026-01-12 | Purchase | 1,112,777.0 | $18.0 |
| GADICKE ANSBERT | TenPercentOwner | 2026-01-12 | Purchase | 1,112,777.0 | $18.0 |
| MPM ASSET MANAGEMENT LLC | TenPercentOwner | 2026-01-12 | Purchase | 1,112,777.0 | $18.0 |
| Oncology Impact Private Investment Fund 2, L.P. | TenPercentOwner | 2026-01-12 | Purchase | 1,112,777.0 | $18.0 |
| Vida Ventures II, LLC | TenPercentOwner | 2026-01-12 | Purchase | 22,545.0 | $18.0 |
| VIDA VENTURES II-A, LLC | TenPercentOwner | 2026-01-12 | Purchase | 22,545.0 | $18.0 |
| Vida Ventures II, LLC | TenPercentOwner | 2026-01-12 | Purchase | 812,455.0 | $18.0 |
| VIDA VENTURES II-A, LLC | TenPercentOwner | 2026-01-12 | Purchase | 812,455.0 | $18.0 |
| Kim Helen Susan | Director,TenPercentOwner | 2026-01-12 | Purchase | 22,545.0 | $18.0 |
| Kim Helen Susan | Director,TenPercentOwner | 2026-01-12 | Purchase | 812,455.0 | $18.0 |
| NODELMAN OLEG | Director | 2026-01-12 | Purchase | 144,443.0 | $18.0 |
| EcoR1 Capital, LLC | Director | 2026-01-12 | Purchase | 144,443.0 | $18.0 |
| NODELMAN OLEG | Director | 2026-01-12 | Purchase | 2,077,779.0 | $18.0 |
| EcoR1 Capital, LLC | Director | 2026-01-12 | Purchase | 2,077,779.0 | $18.0 |